4538.T | Fuso Pharmaceutical Industries,Ltd. Annual &

Annual Balance Sheets

(In JPY)

Breakdown	2024	2023	2022	2021	2020	2019
Total Assets	76.46 Billion	72.46 Billion	69.33 Billion	69.87 Billion	69.15 Billion	71.68 Billion
Total Current Assets	44.94 Billion	43.21 Billion	39.78 Billion	39.53 Billion	38.01 Billion	38.38 Billion
Cash And Short Term Investments	5.12 Billion	8.01 Billion	7.34 Billion	7.07 Billion	7.26 Billion	5.72 Billion
Cash and Cash Equivalents	5.12 Billion	8.01 Billion	7.34 Billion	7.07 Billion	7.26 Billion	5.72 Billion
Short Term Investments	-	-151 Million	-141 Million	-153 Million	-156 Million	-163 Million
Net Receivables	24.32 Billion	22.18 Billion	21.37 Billion	21.59 Billion	20.62 Billion	22.24 Billion
Inventory	14.2 Billion	12.45 Billion	10.51 Billion	10.72 Billion	10.01 Billion	10.29 Billion
Other Current Assets	1.29 Billion	571 Million	557 Million	145 Million	111 Million	130 Million
Total Non-Current Assets	31.51 Billion	29.24 Billion	29.54 Billion	30.33 Billion	31.13 Billion	33.29 Billion
Net PPE	24.42 Billion	23.76 Billion	23.79 Billion	24.63 Billion	25.44 Billion	26.53 Billion
Good Will And Intangible Assets	600 Million	329 Million	453 Million	323 Million	518 Million	753 Million
Good Will	-	-	-	-	-	-
Intangible Assets	600 Million	329 Million	453 Million	323 Million	518 Million	753 Million
Long-Term Investments	3.92 Billion	3.17 Billion	3.23 Billion	3.4 Billion	3.05 Billion	4.1 Billion
Tax Assets	1.05 Billion	678 Million	776 Million	749 Million	854 Million	718 Million
Other Non Current Assets	1.5 Billion	1.3 Billion	1.28 Billion	1.22 Billion	1.25 Billion	1.18 Billion
Other Assets	-	6 Million	4 Million	5 Million	3 Million	6 Million
Total Liabilities	39.79 Billion	36.81 Billion	34.8 Billion	36.19 Billion	36.85 Billion	38.84 Billion
Total Current Liabilities	29.65 Billion	28.47 Billion	26.37 Billion	26.76 Billion	25.7 Billion	26.42 Billion
Account Payables	16.42 Billion	6.04 Billion	6.09 Billion	6.91 Billion	9.63 Billion	9.16 Billion
Tax Payables	270 Million	426 Million	137 Million	725 Million	151 Million	295 Million
Short Term Debt	5.7 Billion	6.88 Billion	6.33 Billion	6.55 Billion	6.85 Billion	7.6 Billion
Deferred Revenue	270 Million	2.79 Billion	2.61 Billion	4.64 Billion	3.05 Billion	4.1 Billion
Other Current Liabilities	7.25 Billion	12.75 Billion	11.32 Billion	8.64 Billion	6.16 Billion	5.55 Billion
Total Non Current Liabilities	10.14 Billion	8.34 Billion	8.42 Billion	9.42 Billion	11.15 Billion	12.41 Billion
Long-Term Debt	7.02 Billion	5.74 Billion	5.75 Billion	6.64 Billion	8.24 Billion	9.39 Billion
Deferred Revenue Non Current	-	1.15 Billion	1.22 Billion	1.34 Billion	1.47 Billion	1.58 Billion
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	1.15 Billion	126 Million	127 Million	125 Million	114 Million	110 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	36.66 Billion	35.64 Billion	34.53 Billion	33.68 Billion	32.3 Billion	32.84 Billion
Stock Holders Equity	36.66 Billion	35.64 Billion	34.53 Billion	33.68 Billion	32.3 Billion	32.84 Billion
Common Stock	10.75 Billion	10.75 Billion	10.75 Billion	10.75 Billion	10.75 Billion	10.75 Billion
Retained Earnings	11.24 Billion	10.51 Billion	9.43 Billion	8.51 Billion	7.41 Billion	7.3 Billion
Accumulated other comprehensive income	2.29 Billion	1.54 Billion	1.5 Billion	1.56 Billion	1.27 Billion	1.93 Billion
Common Stock Equity	36.66 Billion	35.64 Billion	34.53 Billion	33.68 Billion	32.3 Billion	32.84 Billion
Capital Lease Obligation	-	-	1 Million	2 Million	1 Million	4 Million
Total Investments	3.92 Billion	3.01 Billion	3.09 Billion	3.24 Billion	2.9 Billion	3.94 Billion
Total Debt	12.72 Billion	12.63 Billion	12.09 Billion	13.19 Billion	15.09 Billion	17 Billion
Net Debt	7.6 Billion	4.61 Billion	4.74 Billion	6.12 Billion	7.82 Billion	11.27 Billion

Breakdown	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2	2023 Q1
Total Assets	76.9 Billion	76.46 Billion	76.46 Billion	77.7 Billion	76.27 Billion	74.74 Billion
Total Current Assets	46.06 Billion	44.94 Billion	44.94 Billion	47.35 Billion	45.87 Billion	45.21 Billion
Cash And Short Term Investments	5.42 Billion	5.12 Billion	5.12 Billion	6.67 Billion	7.52 Billion	8.08 Billion
Cash and Cash Equivalents	5.42 Billion	5.12 Billion	5.12 Billion	6.67 Billion	7.52 Billion	8.08 Billion
Short Term Investments	-	-	-	-	-	-
Net Receivables	25.23 Billion	24.32 Billion	24.32 Billion	26.27 Billion	23.86 Billion	22.78 Billion
Inventory	14.06 Billion	14.2 Billion	14.2 Billion	13.21 Billion	13.34 Billion	13.2 Billion
Other Current Assets	1.35 Billion	1.29 Billion	1.29 Billion	1.18 Billion	1.13 Billion	1.14 Billion
Total Non-Current Assets	30.84 Billion	31.51 Billion	31.51 Billion	30.35 Billion	30.4 Billion	29.53 Billion
Net PPE	24.17 Billion	24.42 Billion	24.42 Billion	24.6 Billion	24.52 Billion	24.05 Billion
Good Will And Intangible Assets	806 Million	600 Million	600 Million	447 Million	433 Million	322 Million
Good Will	-	-	-	-	-	-
Intangible Assets	806 Million	600 Million	600 Million	-	-	-
Long-Term Investments	-	3.92 Billion	3.92 Billion	-	-	-
Tax Assets	-	1.05 Billion	1.05 Billion	-	-	-
Other Non Current Assets	5.86 Billion	1.5 Billion	1.5 Billion	5.3 Billion	5.44 Billion	5.16 Billion
Other Assets	-	-	-	-	3 Million	1 Million
Total Liabilities	39.64 Billion	39.79 Billion	39.79 Billion	41.62 Billion	40.39 Billion	38.74 Billion
Total Current Liabilities	34.07 Billion	29.65 Billion	29.65 Billion	31.2 Billion	30.72 Billion	30.16 Billion
Account Payables	15.28 Billion	16.42 Billion	16.42 Billion	16.86 Billion	7.42 Billion	6.95 Billion
Tax Payables	115 Million	270 Million	270 Million	147 Million	398 Million	71 Million
Short Term Debt	11.02 Billion	5.7 Billion	5.7 Billion	6.31 Billion	6.48 Billion	6.06 Billion
Deferred Revenue	115 Million	270 Million	270 Million	147 Million	1.29 Billion	521 Million
Other Current Liabilities	7.66 Billion	7.25 Billion	7.25 Billion	7.88 Billion	15.51 Billion	16.62 Billion
Total Non Current Liabilities	5.57 Billion	10.14 Billion	10.14 Billion	10.42 Billion	9.67 Billion	8.57 Billion
Long-Term Debt	3.22 Billion	7.02 Billion	7.02 Billion	7.96 Billion	7.19 Billion	6.01 Billion
Deferred Revenue Non Current	-	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	2.34 Billion	1.15 Billion	1.15 Billion	2.46 Billion	2.48 Billion	2.56 Billion
Other Liabilities	-	-	-	-	-	-
Total Equity	37.25 Billion	36.66 Billion	36.66 Billion	36.07 Billion	35.87 Billion	36 Billion
Stock Holders Equity	37.25 Billion	36.66 Billion	36.66 Billion	36.07 Billion	35.87 Billion	36 Billion
Common Stock	10.75 Billion	10.75 Billion	10.75 Billion	10.75 Billion	10.75 Billion	10.75 Billion
Retained Earnings	16.87 Billion	11.24 Billion	11.24 Billion	16.39 Billion	16.17 Billion	15.94 Billion
Accumulated other comprehensive income	1.89 Billion	6.93 Billion	2.29 Billion	1.37 Billion	1.39 Billion	1.1 Billion
Common Stock Equity	37.25 Billion	36.66 Billion	36.66 Billion	36.07 Billion	35.87 Billion	36 Billion
Capital Lease Obligation	-	-	-	-	-	-
Total Investments	-	3.92 Billion	3.92 Billion	5.3 Billion	5.44 Billion	5.16 Billion
Total Debt	14.25 Billion	12.72 Billion	12.72 Billion	14.27 Billion	13.68 Billion	12.08 Billion
Net Debt	8.83 Billion	7.6 Billion	7.6 Billion	7.59 Billion	6.16 Billion	4 Billion

Balance Sheet Charts

Cloudbreak Discovery Plc

CDBDF

Full Analysis

Annual Balance Sheets
Upper Street Marketing Inc.

UPPR

Full Analysis

Annual Balance Sheets
Tana Resources Corp.

TANA

Full Analysis

Annual Balance Sheets
MPC Container Ships ASA

MPZZF

Full Analysis

Annual Balance Sheets
Rifa Co.,Ltd.

000760

Full Analysis

Annual Balance Sheets
Jiangxi Synergy Pharmaceutical Co., Ltd.

300636

Full Analysis

Annual Balance Sheets

Global Stocks Search

Fuso Pharmaceutical Industries,Ltd. (4538.T)

Annual Balance Sheets

Balance Sheet Charts

Cloudbreak Discovery Plc

Upper Street Marketing Inc.

Tana Resources Corp.

MPC Container Ships ASA

Rifa Co.,Ltd.

Jiangxi Synergy Pharmaceutical Co., Ltd.